Hyundai Hope on Wheels and Raleigh-Durham Area Hyundai dealers awarded Ian Davis, MD, PhD, a $100,000 grant to support research into the causes of and treatments for pediatric sarcoma.
The UNC Center for AIDS Research (CFAR) plays an active role in education and outreach, and provides developmental grant awards to support new ideas and new investigators in HIV/AIDS research.
The rise of “austerity politics” has important implications for health policy, says Jon Oberlander, PhD, professor of health policy and management at the University of North Carolina at Chapel Hill’s Gillings School of Global Public Health and professor of social medicine in the UNC School of Medicine.
Stefanie Sarantopoulos, MD, PhD, has received two grants that have helped establish her own laboratory to look into the causes of chronic graft-versus-host disease.
A new study by UNC researchers finds that an inexpensive set of infection control measures could potentially save many thousands of lives and billions of dollars.
At work, Dr. William Goodnight takes care of women with high-risk pregnancies. At play, he likes to mountain bike. And run trails. And do a little white water kayaking -- all on the same day.
A new study, conducted in part at UNC, finds that a 24-week triple medication treatment course for hepatitis C is just as effective as a 48-week regimen.
More hurricanes and tropical storms hit North Carolina in September than in any other month. Two UNC experts explain how state residents can stay safe and healthy before and after a dangerous storm.
The professorship, established by a $500,000 gift from Wally (class of ’66) and Lil Loewenbaum of Austin, Texas, is named in honor of Mr. Loewenbaum’s grandfather, Dr. Sidney K. Simon.
Clara Lee, MD, MPP, a UNC School of Medicine physician/scientist, will use the five-year NIH grant to examine patients’ decision-making process about reconstruction and the effects of reconstruction on quality of life and body image.
The UNC Department of Psychiatry and the UNC Center for Women's Mood Disorders have opened a 5-bed unit for women with moderate to severe post-partum depression (PPD). The unit is the first of its kind in the United States.
The study of more than 50,000 adults ages 18 and older provides new molecular evidence that 11 DNA regions in the human genome have strong association with these diseases, including six regions not previously observed.
This finding by UNC researchers lends insight into key cells, called Foxp3-expressing regulatory T cells or Tregs, which are currently being tested as treatments for diseases such as type I diabetes, arthritis and lupus.
Treatment for a benign tumor at the base of her skull helps a Sampson County native and Veteran’s Administration hospital nurse get everything else right in her head and be on alert for the unexpected blessings of life.
A new type of nanoparticle developed in the laboratories at the University of North Carolina has shown potential for more effective delivery of chemotherapy to treat cancer.
The professorship was established with a gift from Dr. L.Y. Soo, a 1955 graduate of University of North Carolina at Chapel Hill, and his wife, Dr. Dixie Lee Boney Soo of Chapel Hill, N.C.
A study from the UNC School of Medicine has illuminated a key step of demethylation, giving stem cell researchers critical information as they try to reprogram adult cells to mimic the curative and self-renewing properties of stem cells.
UNC researchers tested the implementation and impact of a model curriculum to promote wellness and motivation to quit tobacco use in psychosocial rehabilitation clubhouses. Results show that the program helped clubhouse members reduce tobacco use and advanced smoke-free policy change.
A team of UNC scientists report that in laboratory studies, overexpression of a specific protein could be used as a prognostic marker and as a guide for therapeutic choices for patients with head and neck cancer.
A new study led by researchers at the University of North Carolina at Chapel Hill finds that there may be a limit to how early the therapy, known as HAART, should start.
The University of North Carolina at Chapel Hill has received a $3 million, five-year grant from the National Institute of Diabetes and Digestive and Kidney Diseases to establish the UNC Center for Diabetes Translation Research to Reduce Health Disparities (CDTR).
The award recognizes the promise that Thomas L. Kash, PhD, has demonstrated as a scientist and his research program on the effects of alcohol on neural circuits in the brain.
An innovative partnership between UNC and the North Carolina Community Health Center Association (NCCHA) is bringing a toolkit offering best practices for improving colorectal cancer screening rates to 136 clinics across the state.
G-Zero Therapeutics, an RTP company started in 2008 based on technologies from the University of North Carolina at Chapel Hill, has been awarded a $3 million Phase II Small Business Innovation Research Grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.